The evolving epidemiology of valvular aortic stenosis. The Tromsø Study

Objective To assess prevalence, incidence, prognosis and progression of degenerative valvular aortic stenosis (AS). Setting The Tromsø Study and the University Hospital of North Norway. Design Population based prospective study. Population Over a 14 year span we performed three repeated echocardiographic examinations (1994, 2001 and 2008) of a random sample of initially 3273 participants. Data from the only hospital serving this population were included. Results There were 164 subjects with AS. Prevalence consistently increased with age, average values being 0.2% in the 50–59 year cohort, 1.3% in the 60–69 year cohort, 3.9% in the 70–79 year cohort and 9.8% in the 80–89 year cohort. The incidence rate in the study was 4.9‰/year. The mean annual increase in mean transvalvular pressure gradient was 3.2 mm Hg. The increase was lower in mild AS than in more severe disease, disclosing a non-linear development of the gradient, but with large individual variations. Mortality was not significantly increased in the asymptomatic AS-group (HR=1.28), nor in those who received aortic valve replacement (n=34, HR=0.93), compared with the general population. Conclusion This is the first study to document the incidence and prognosis of AS in a general population with surgery as a treatment option. It reveals an accelerated progression of the aortic mean gradient as the disease advances. The prognosis of AS seems to be comparable with the normal population in the asymptomatic stage and after successful surgery, indicating that the follow-up and timing of surgery has been adequate for this patient group.

[1]  H. Schirmer,et al.  Mitral flow derived Doppler indices of left ventricular diastolic function in a general population; the Tromso study. , 2000, European heart journal.

[2]  S. Rahimtoola,et al.  Severe Aortic Stenosis in Patients 60 Years of Age and Older: Left Ventricular Function and 10‐year Survival After Valve Replacement , 1981, Circulation.

[3]  F. Neumann,et al.  Inconsistent grading of aortic valve stenosis by current guidelines: haemodynamic studies in patients with apparently normal left ventricular function , 2010, Heart.

[4]  J. Heikkilä,et al.  Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. , 1993, Journal of the American College of Cardiology.

[5]  J. Gardin,et al.  Burden of valvular heart diseases: a population-based study , 2006, The Lancet.

[6]  M. Schemper,et al.  Predictors of outcome in severe, asymptomatic aortic stenosis. , 2000, The New England journal of medicine.

[7]  S. Pocock,et al.  Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. , 2010, The New England journal of medicine.

[8]  C M Otto,et al.  Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. , 1997, Circulation.

[9]  A. Gown,et al.  Characterization of the Early Lesion of ‘Degenerative’ Valvular Aortic Stenosis: Histological and Immunohistochemical Studies , 1994, Circulation.

[10]  J. Chambers,et al.  Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[11]  B. Carabello,et al.  Aortic stenosis , 2018, Rapid Cardiac Care.

[12]  Franz Schwarz,et al.  The Effect of Aortic Valve Replacement on Survival , 1982, Circulation.

[13]  J. Chambers,et al.  Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. , 2008, The New England journal of medicine.

[14]  Tom Wilsgaard,et al.  Cohort profile: The Tromsø Study , 2011, International journal of epidemiology.

[15]  R. Prescott,et al.  A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. , 2005, The New England journal of medicine.

[16]  W. Roberts,et al.  Frequency by Decades of Unicuspid, Bicuspid, and Tricuspid Aortic Valves in Adults Having Isolated Aortic Valve Replacement for Aortic Stenosis, With or Without Associated Aortic Regurgitation , 2005, Circulation.

[17]  K. Teo,et al.  Effect of Lipid Lowering With Rosuvastatin on Progression of Aortic Stenosis: Results of the Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) Trial , 2010, Circulation.

[18]  M. Enriquez-Sarano,et al.  Aortic valve stenosis in community medical practice: determinants of outcome and implications for aortic valve replacement. , 2012, The Journal of thoracic and cardiovascular surgery.

[19]  J. Heikkilä,et al.  Natural history of aortic valve stenosis of varying severity in the elderly. , 1996, The American journal of cardiology.

[20]  M. Schemper,et al.  Statins but Not Angiotensin-Converting Enzyme Inhibitors Delay Progression of Aortic Stenosis , 2004, Circulation.

[21]  C. Otto,et al.  Aortic Stenosis: Clinical Aspects of Diagnosis and Management, With 10 Illustrative Case Reports From a 25-Year Experience , 2010, Medicine.

[22]  Catherine M. Otto,et al.  Clinical Factors Associated With Calcific Aortic Valve Disease , 1997 .

[23]  F. Neumann,et al.  Inconsistencies of echocardiographic criteria for the grading of aortic valve stenosis. , 2008, European heart journal.

[24]  K. Bailey,et al.  Outcome of 622 Adults With Asymptomatic, Hemodynamically Significant Aortic Stenosis During Prolonged Follow-Up , 2005, Circulation.

[25]  S. Yun,et al.  Early Surgery Versus Conventional Treatment in Asymptomatic Very Severe Aortic Stenosis , 2010, Circulation.

[26]  G. Nickenig,et al.  Prognosis of octogenarians with severe aortic valve stenosis at high risk for cardiovascular surgery , 2010, Heart.

[27]  F. Veglia,et al.  Do statins improve outcomes and delay the progression of non-rheumatic calcific aortic stenosis? , 2011, Heart.

[28]  M. Schemper,et al.  Natural History of Very Severe Aortic Stenosis , 2010, Circulation.